Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Clinical trial NCT00449761 · TERMINATED
Trial details
- NCT number
- NCT00449761
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-23
- Primary completion
- 2008-01-29
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.